Flora Growth Corp. DEF 14A: Executive Compensation Details
Ticker: ZSTK · Form: DEF 14A · Filed: May 6, 2025 · CIK: 1790169
| Field | Detail |
|---|---|
| Company | Flora Growth Corp. (ZSTK) |
| Form Type | DEF 14A |
| Filed Date | May 6, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, stock-options, corporate-governance, DEF-14A
Related Tickers: FLGC
TL;DR
Flora Growth Corp. DEF 14A out - exec comp & stock options for Clifford Starke, Sammy Dorf, Luis Merchan detailed for FY24.
AI Summary
Flora Growth Corp. filed a DEF 14A on May 6, 2025, detailing executive compensation and corporate governance for the fiscal year ending December 31, 2024. The filing includes information on stock options and stock appreciation rights granted to directors and officers such as Clifford Starke, Sammy Dorf, and Luis Merchan.
Why It Matters
This filing provides transparency into how Flora Growth Corp. compensates its top executives and directors, which can influence investor decisions and perceptions of the company's management.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine disclosures, but the specifics of executive compensation and stock option grants can reveal insights into management's confidence and potential future stock performance.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period for which executive compensation is detailed.)
- 20250506 — Filing Date (The date the DEF 14A was filed with the SEC.)
Key Players & Entities
- Flora Growth Corp. (company) — Filer of the DEF 14A
- Clifford Starke (person) — Executive/Director mentioned in compensation details
- Sammy Dorf (person) — Executive/Director mentioned in compensation details
- Luis Merchan (person) — Executive/Director mentioned in compensation details
- newsfilecorp.com (company) — Filer of the DEF 14A
FAQ
What is the total number of stock options granted to directors in 2024?
The filing indicates that for the fiscal year ending December 31, 2024, 'Director1Member' and 'Director2Member' were associated with 'us-gaap:EmployeeStockOptionMember' and 'us-gaap:StockAppreciationRightsSARSMember', but specific quantities are not detailed in this excerpt.
What is the fiscal year end for Flora Growth Corp. as reported in this filing?
The Conformed Period of Report is 20250630, and the Fiscal Year End is 1231, indicating the reporting period covers up to June 30, 2025, with the fiscal year ending December 31.
Who are the key individuals whose compensation details are highlighted?
Key individuals mentioned in relation to compensation and stock awards for the fiscal years 2023 and 2024 include Clifford Starke, Sammy Dorf, Dany Vaiman, Luis Merchan, Hussein Rakine, and Matthew Cohen.
What type of financial instruments are being disclosed in relation to executive compensation?
The filing discloses information related to 'us-gaap:EmployeeStockOptionMember' and 'us-gaap:StockAppreciationRightsSARSMember' for various directors and individuals.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted on May 6, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on May 6, 2025 by Clifford Starke regarding Flora Growth Corp. (ZSTK).